Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation

NAActive, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2025

Conditions
Obstructive Sleep ApneaOSAApneaApnea, ObstructiveApnea, Obstructive SleepApnea+HypopneaHypopnea, Sleep
Interventions
DEVICE

Hypoglossal Nerve Stimulation

Hypoglossal Nerve Stimulation started at Month 1 compared to no Stimulation (Control group will start stimulation at M7+1Day)

Trial Locations (20)

10024

Weill Cornell Medical College, New York

17033

Penn State Health, Hershey

19107

Philadelphia Ear, Nose and Throat Associates, Philadelphia

27607

Raleigh Neurology Associates, Pa, Raleigh

29201

Bogan Sleep Consultants, Llc, Columbia

29425

Medical University of South Carolina, Charleston

30342

Advanced Ent Associates, Atlanta

33126

Sleep Medicine Specialists of South Florida, Miami

34695

Morton Plant Mease Health Care, Safety Harbor

35294

University of Alabama At Birmingham, Birmingham

40218

Norton Healthcare, Louisville

68526

Alivation Research Llc, Lincoln

75154

Epic Medical Research, Red Oak

77030

Houston Methodist, Houston

84108

University of Utah, Salt Lake City

85006

Banner Health, Phoenix

85724

University of Arizona, Tucson

92130

Paul Schalch Lepe, Md/Silenso Clinic, San Diego

95661

Sacramento Ent, Roseville

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LivaNova

INDUSTRY

NCT04950894 - Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation | Biotech Hunter | Biotech Hunter